Three-fourths of kidney transplant patients in a small trial avoided long-term immunosuppression using a donor-derived cellular therapy. No deaths, graft loss, or complications occurred in the ...

Inducing temporary chimerism by transplanting donor Tregs and bone marrow after kidney transplantation was successful in a phase 1 and 2a trial. The hope is that it will reduce the risk for graft loss ...

Successful kidney transplants rely on the biological compatibility of the donor and recipient but still require long-term use of drugs to tamp down the recipient's immune system and prevent donor ...

Please provide your email address to receive an email when new articles are posted on . A phase 3 clinical trial showed that chimerism was successful in preventing organ rejection in patients with ...

A team of researchers led by Tatsuo Kawai of Massachusetts General Hospital, Department of Surgery, Harvard Medical School, Boston, has found a less-intensive way to promote bone marrow transfusion ...

Please provide your email address to receive an email when new articles are posted on . Transplantation of stem cells prior to the patient receiving the donor kidney prevented use of long-term ...

Localized Pelvic Neuroblastoma: Excellent Survival and Low Morbidity With Tailored Therapy—The 10-Year Experience of the French Society of Pediatric Oncology We recently reported that children with ...